BioInnovatise Launches New Adenovirus Packaging Service for Accelerating Research and Development
Molecular Cloning & Mutagenesis Projects Completed
Viral Vector Packaging Solutions Delivered
Plasmid DNA Preparations Successfully Produced
BioInnovatise Launches New Adenovirus Packaging Service for Accelerating Research and Development
November 18, 2024
Rockville, MD — BioInnovatise is proud to announce the introduction of its new Adenovirus Packaging Service, designed to enhance the capabilities of early discovery phase research and development. As part of our commitment to advancing scientific discovery, BioInnovatise offers fast, reliable, and high quality contract development and manufacturing organization (CDMO) services for viral vector based research, including adenovirus packaging.
With over 30,000 cloning constructs produced, 100+ lentiviral vectors packaged, and more than 1,000 plasmid DNA preparations, BioInnovatise is prepared to meet your viral vector, including adenovirus packaging, lentivirus packaging, and retrovirus packaging, needs efficiently. Our quick turnaround times ensure that projects proceed without unnecessary delays.
BioInnovatise’s new adenovirus packaging service perfectly complements our existing retrovirus and lentivirus offerings, providing researchers with a comprehensive range of viral vectors for early discovery-phase R&D. Together, these services give researchers flexible, tailored options to meet the diverse needs of gene therapy, immunology, and oncology research, accelerating progress toward groundbreaking discoveries.
Quick Turnaround Adenoviral Packaging for Research and Development
If you are uncertain about which packaging service is best for your research, our viral vector team is available to assist you. Our adenoviral research grade viral vector services include:
- Crude (for in vitro): ~10E11 IFU/ml | Available in 250 μl, 500 μl, and 1 ml volumes.
- Ultracentrifugation purified (for in vitro or in vivo): ~10E12 IFU/ml l | Available in 250 μl, 500 μl, and 1 ml volumes.
Adenovirus Packaging Production Options
- Cell Lines: Adenovirus transductions are performed using a HEK293T cell line (Human Embryonic Kidney 293 Transient) to ensure high transfection efficiency.
- Transfection Protocol: Adenovirus packaging is produced according to client specifications. If you lack a adenovirus transfection protocol, we can assist in developing one suited to your research needs.
- Quality Control: All adenovirus productions have titer levels measured with a RT-qPCR assay. Additional quality control tests are available upon request, including A260/A280, flow cytometry, and Western blot/ELISA analyses.
About BioInnovatise
BioInnovatise is a leading CDMO specializing in high-quality support for plasmid DNA and viral vector research. Our services are designed to deliver efficient and reliable solutions for advancements in cell and gene therapy, immunotherapy, precision medicine, and more.
Adenovirus Packaging Resources
Trusted By Top Researchers Across Disciplines and Therapeutic Areas
Subscribe for Product Releases, New Resources, and Company Updates
13 Taft Court Suite 220
Rockville, MD 20850
(301) 838-8675
Follow Us on LinkedIn
© 2025 BioInnovatise, All Rights Reserved